This study aims to identify potential biomarkers of hepatocellular carcinoma (HCC) occurrence/recurrence and obesity, along with the molecular mechanisms that involve these biomarkers. Three ...

Cogenics, a division of Clinical Data Inc. and comprised of the combined companies of Genaissance Pharmaceuticals, Lark (US and UK), Icoria, and Genome Express of France, have joined with other ...

BUFFALO, N.Y. -- A multidisciplinary team of pharmaceutics and computer-science researchers at the University at Buffalo, one of very few teams in the nation applying DNA microarray technology in ...

The research community's rapid acceptance of microarrays notwithstanding, technical challenges remain. Biochip developers continue to grapple with these issues while upgrading their offerings and ...

Farmington, Jan. 09, 2023 (GLOBE NEWSWIRE) -- The Global Microarrays Market size was estimated at USD 3.72 Billion in 2022 and is expected to surpass USD 8.15 Billion by 2030, expanding at a CAGR of 8 ...